2014


Basel-Stadt


@cellestiabio Homepage

Company profile

Cellestia Biotech

Some forms of cancer develop due to communication problems between cells. The active ingredient developed by Cellestia targets this miscommunication specifically. It could therefore be used to fight leukaemia, lymphoma and solid tumours. Last winter, Cellestia completed a financing round to the tune of CHF 8 million. There are plans to conduct the first tests on human subjects before the end of this year.


Source: startup.ch

Highlights

More news about Cellestia Biotech

20.12.2018 12:06

Cellestia Biotech raises CHF 20 million

Financing
Please login or
register to use the
bookmark feature
09.05.2018 16:20

Ten startup founders are set for China

Award
Please login or
register to use the
bookmark feature
11.01.2018 11:04

New startup investments by the Go Beyond community

Financing
Please login or
register to use the
bookmark feature
08.01.2018 09:01

Cellestia’s clinical study has started

Success
Please login or
register to use the
bookmark feature
14.08.2017 17:18

Cellestia enters clinical development for its lead compound

Success
Please login or
register to use the
bookmark feature
30.03.2017 17:08

18 Jungunternehmen auf dem Weg zum SEF.Award

Award
Please login or
register to use the
bookmark feature
27.01.2017 13:20

Cellestia Biotech raises CHF 8 million seed financing

Financing
Please login or
register to use the
bookmark feature
23.12.2016 09:32

Go Beyond: more than 2.2 Million invested in Startups

FinancingBackground
Please login or
register to use the
bookmark feature
19.09.2016 10:34

Jungunternehmerpreis Nordwestschweiz: Die Finalisten stehen fest

Award
Please login or
register to use the
bookmark feature
07.03.2016 13:50

Pre-Seed Workshop 2016: Transforming ideas into viable ventures

Support
Please login or
register to use the
bookmark feature

Principal

22.02.2019
Editorial

Getting ready for growth

Partners

Contributors

By continuing to use this website you agree with our TERMS AND CONDITIONS